15353-j-veluchamy

166 | Chapter 7 anti-tumor immune response in immunosuppressed cancer patients. Soon, UCB-NK cell functions, and thereby antitumor efficacy, may be further improved by genetic modification or combination therapy approaches encompassing novel immune modulatory genes or agents as outlined in chapter 6.